The only official magazine of The Cleaning Show

Double-sided 'tiger stripe' waste bags

Published 1st July, 2013 by Neil Nixon

Double-sided 'tiger stripe' waste bags

GV Health has launched double-sided 'tiger stripe' offensive waste bags. Non-infectious offensive waste is the fastest growing healthcare waste type but is often confused with clinical waste. The distinctive markings on GV Health's new double-sided 'tiger stripe' bags make them easy to identify and reduce waste disposal errors by nursing and medical staff. Double-sided 'tiger stripe' offensive waste bags provide a simple and effective solution for hospitals and clinics seeking to improve the accuracy of waste segregation and to control spiralling healthcare waste disposal costs.

The offensive waste channel has seen a huge increase use among healthcare providers over the past few years in response to environmental concerns over incineration and the high cost of clinical waste disposal. While not suitable for all clinical waste, a large percentage of healthcare waste can be processed through the offensive waste channel. Taking full advantage of this requires accurate separation of different types of waste by medical and nursing staff.

Strict colour coding and labeling is required on bags used for healthcare waste. Offensive waste bags are distinguished by a lengthways black stripe down the yellow bags which are otherwise identical to clinical waste bags. This has resulted in frequent errors, particularly when bags are partially obscured in bins. A number of health authorities have reported lower than expected take-up for offensive waste channels as a result of staff misunderstandings and errors.

Responding to these concerns, GV Health has developed a new design for offensive waste bags. Multiple stripes are printed down both sides of the bag to facilitate easy identification at a glance, even when only the bag top is visible in a bin. The new multiple stripe design meets regulatory standards and initial customer feedback has been overwhelmingly positive with trials on-going in a number of leading NHS hospitals.

Article links